Cell Biology

J.W. Harper, G.R. Adami, N. Wei, K. Keyomarsi, S.J. Elledge, "The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases," Cell, 75:805-16, 1993. (Cited in nearly 500 publications through September 1995) Comments by Stephen J. Elledge and J. Wade Harper, Baylor College of Medicine "This paper describes the identification and characterization of the first human gene encoding a protein- p21Cip1-which functions to negatively regulate Cdks controlling cell-cycle en

Written byNeeraja Sankaran
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Comments by Stephen J. Elledge and J. Wade Harper, Baylor College of Medicine

"This paper describes the identification and characterization of the first human gene encoding a protein- p21Cip1-which functions to negatively regulate Cdks controlling cell-cycle entry," remarks Stephen Elledge, a professor of biochemistry at the Baylor College of Medicine and an investigator in the Howard Hughes Medical Institute there.

"Specific kinases called Cdk2 and Cdk4 are believed to play a critical role in helping a cell decide whether or not to enter into the cell cycle-the process in which a cell duplicates its DNA and organelles in order to form two new cells," explains Wade Harper, an associate professor of biochemistry at Baylor. "In this paper we discovered a novel protein that could bind tightly and specifically with these Cdks and block their ability to phosphorylate critical substrates.

"We now know that p21 is a member of a family ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies